Related Experiment Video
Updated: Jun 25, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
Single-cell analysis of adaptive NK and CMV-specific T-cell dynamics after allogeneic HSCT
Aino Elina Hakkinen1,2,3, Jani Huuhtanen1,2,3,4, Sofie Lundgren1,2,3
1Translational Immunology Research Program, University of Helsinki, Helsinki, Finland.
Abstract:
Cytomegalovirus (CMV) reactivation reshapes immune reconstitution and remains a significant cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (HSCT). To understand the impact of asymptomatic CMV viremia on immune reconstitution, we profiled longitudinal blood samples (n = 32) from donor-recipient pairs before and after HSCT with single-cell RNA and T-cell receptor (TCR) sequencing for 3 months after transplantation. To analyze the development of antigen-specific T-cell responses in detail, we sorted and TCR-sequenced T cells specific to the immunodominant CMV epitope pp65. After HSCT, an early increase in CD14+ monocytes was observed, followed by expansion of T and natural killer (NK) cells. Persisting patient-cell chimerism was observed in the CD4+ T-cell fraction. CMV-specific T cells and CMV-associated adaptive NK cells matured slower in grafts from seronegative donors compared to those from seropositive donors. The early maturation of adaptive NK cells was markedly more rapid in patients with CMV-seropositive donors, with enhanced recall function; however, adaptive NK cell cytotoxicity was higher in patients with CMV-seronegative donors. Large oligoclonal CD8+ T-cell expansions against the immunodominant CMV pp65NLV epitope comprised up to 63.6% of the CD8+ T-cell repertoire, showing terminal maturation with upregulation of canonical NK cell receptors. Our study presents, to our knowledge, the first comprehensive single-cell transcriptomic characterization of adaptive immune recovery after allogeneic HSCT, with a particular focus on CMV reactivation. Our findings highlight the impact of donor CMV serostatus on immune maturation in recipients with CMV reactivation, which may help predict the timing of immune reconstitution and inform strategies for management of posttransplant complications.

